Market map · clinic operations software · Jul 2026
Four segments serve clinic scheduling, and only one of them takes an action without a human. That is the segment we are in, and it is currently the least crowded — because acting requires write-back, clinical guardrails, and the trust to send a message on the clinic’s behalf.
The other three segments compete on showing information; ours competes on removing work. A legacy PMS cannot act because scheduling is not its product, point tools cannot act because they do not own write-back, and horizontal schedulers cannot act because they have no model of clinical urgency. The defensible position is not the interface — it is being trusted to text a patient and book them without asking anyone first, which takes integration depth and a guardrail model that a general-purpose tool has no reason to build.
01↗
Two waitlist tools were acquired by PMS vendors in the last year. Expect scheduling features to be absorbed into the system of record, badly, over the next 24 months.
02→
Patient-access and operations directors now hold the budget in groups above eight sites. They buy measured hours, not features — a different pitch entirely.
03↘
Two general booking platforms quietly dropped healthcare-specific pages this year. Compliance overhead is pushing them back to easier verticals.
Segments and players are illustrative of the landscape as of Jul 2026; funding and headcount figures are public where available. Maintained by Jonah Trell, reviewed quarterly.